Nutex Health (NASDAQ:NUTX) Downgraded to Hold Rating by Wall Street Zen

Nutex Health (NASDAQ:NUTX) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “hold” rating in a research note issued on Saturday.

Separately, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Nutex Health in a report on Monday, December 29th. Two investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, Nutex Health presently has an average rating of “Moderate Buy” and an average price target of $252.50.

Nutex Health Trading Down 14.3%

NASDAQ:NUTX opened at $90.28 on Friday. The company has a market cap of $638.28 million, a PE ratio of 10.05 and a beta of 0.03. The business’s 50 day moving average is $136.67 and its two-hundred day moving average is $124.50. The company has a quick ratio of 3.18, a current ratio of 3.20 and a debt-to-equity ratio of 0.67. Nutex Health has a 52 week low of $40.67 and a 52 week high of $193.07.

Nutex Health (NASDAQ:NUTX) last posted its quarterly earnings results on Thursday, March 5th. The company reported $1.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.56 by ($3.95). The firm had revenue of $151.68 million for the quarter, compared to analyst estimates of $258.82 million. Nutex Health had a net margin of 7.34% and a return on equity of 18.70%.

Institutional Investors Weigh In On Nutex Health

Several large investors have recently added to or reduced their stakes in the stock. Pacer Advisors Inc. lifted its stake in Nutex Health by 4.3% in the fourth quarter. Pacer Advisors Inc. now owns 33,289 shares of the company’s stock valued at $5,480,000 after buying an additional 1,359 shares during the last quarter. Mcguire Capital Advisors Inc. bought a new position in shares of Nutex Health during the fourth quarter worth about $165,000. Invesco Ltd. increased its holdings in shares of Nutex Health by 142.4% in the 4th quarter. Invesco Ltd. now owns 4,892 shares of the company’s stock worth $805,000 after acquiring an additional 2,874 shares during the period. Mackenzie Financial Corp acquired a new stake in shares of Nutex Health in the 4th quarter worth about $425,000. Finally, XTX Topco Ltd lifted its position in Nutex Health by 93.8% in the 4th quarter. XTX Topco Ltd now owns 5,443 shares of the company’s stock valued at $896,000 after purchasing an additional 2,634 shares during the last quarter. 5.32% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting Nutex Health

Here are the key news stories impacting Nutex Health this week:

• Positive Sentiment: Nutex reported strong full‑year 2025 results (revenue +82% y/y to $875.3M; net income and EPS up; adjusted EBITDA +152.6%) and announced a second stock repurchase program — news that can support the stock over time by reducing share count and signaling management confidence. NUTEX HEALTH REPORTS 2025 FINANCIAL RESULTS AND ANNOUNCES SECOND STOCK REPURCHASE PROGRAM
• Positive Sentiment: Analyst/coverage pieces are discussing valuation upside given earnings growth and the buyback, which may attract long‑term investors focused on fundamentals. Assessing Nutex Health (NUTX) Valuation After Earnings Growth And New Share Buyback Program
• Neutral Sentiment: Corporate press releases and financial filings provide the detailed numbers and management commentary — useful for investors doing due diligence but unlikely to move the market on their own. Company Press Release / Financial Report
• Negative Sentiment: Nutex’s most recent quarterly report missed expectations sharply (EPS $1.61 vs. $5.56 est.; revenue $151.7M vs. $258.8M), a short‑term catalyst for selling as it signals volatility in recent revenue drivers. MarketBeat: Earnings Summary
• Negative Sentiment: Multiple law firms (Block & Leviton, Kuehn Law and others) have launched investigations or encouraged shareholders to contact them over potential securities fraud and fiduciary‑duty claims tied to disclosure of revenue recognition and internal controls — a major overhang that raises litigation risk, potential settlements, and reputational damage. Block & Leviton Investigation Notice
• Negative Sentiment: Additional press items detail similar shareholder litigation allegations about HaloMD-related revenue recognition, internal control weaknesses, and stock‑based compensation treatment — issues that could lead to restatements or future liabilities. Kuehn Law Notice
• Negative Sentiment: Local/regional reporting highlights investor outreach from law firms, amplifying negative headlines and short‑term selling pressure. GazetteXtra: Investor Advisory

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.